cfDNA for Liquid Biopsy for Patients With Glioblastoma

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

S. Bagley

2024 Neuro-Oncology Update: Brain Tumors

Scripps Health

T. McGranahan

Nutrition + Supplements in Cancer: Do's and Don'ts

Scripps Health

D. Abrams

Overview and Updates in Brain Tumors

Henry Friedman

RANO 2.0 and Advances in Neuroimaging: Impact on Clinical Trials and…

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

S. Mohan

Oncologists' Perspectives on the Effects of Time Toxicity in Cancer …

Safiya Karim

Best Practices for the Provider Approach in Treating Patients With I…

Katherine Peters

Overview of CNS Cancers

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

V. Venur

Updates on Glioblastoma

Dana-Farber Cancer Institute

D. Reardon

ESMO 2024 Summary: The Emerging Global Epidemic of Early-Onset Cance…

2024 ESMO Annual Meeting Insights Hub

S. Ogino

Clinical Implications of Tumor Agnostic Therapies

Shivaani Kummar

Delayed Diagnosis and Diagnostic Imprinting in Pediatric CNS Tumors:…

Ibrahim Qaddoumi

Palliative Medicine in Cancer Patients

Houston Methodist

E. De Leon

Medical and Symptom Management of Patients With Brain Tumors

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

A. Pruitt

The Future of Lung Cancer Care

Yale Cancer Center

M. Davies

Overcoming Barriers to Extend Survival: Promising Results of Clinica…

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

S. Brem

ASCO® 2023 Insights: "Expanding the Benefit - Dabrafenib/Trametinib …

Insights from 2023 ASCO® Annual Meeting

V. Subbiah

Seizure Management for Brain Tumor Survivors: Current Concepts

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

S. Sinha

Surgical Approaches for Brain Tumors

Dana-Farber Cancer Institute

W. Linda Bi, O. Arnaout

2024 Updates on Near-Infrared Fluorescent Imaging for Brain Tumors

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

J. Lee